Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
about
P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction.Presenilin 2 deficiency facilitates Aβ-induced neuroinflammation and injury by upregulating P2X7 expression.Pathological overproduction: the bad side of adenosine.The Role of Adenosine A2A Receptor, CYP450s, and PPARs in the Regulation of Vascular Tone.Aβ Peptide Originated from Platelets Promises New Strategy in Anti-Alzheimer's Drug Development.Purinergic Signalling: Therapeutic Developments.Activation of G-protein-gated inwardly rectifying potassium (Kir3/GirK) channels rescues hippocampal functions in a mouse model of early amyloid-β pathology.The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy.Caffeine Neuroprotective Mechanism Against β-Amyloid Neurotoxicity in SHSY5Y Cell Line: Involvement of Adenosine, Ryanodine, and N-Methyl-D-Aspartate Receptors.Association of cerebrovascular dysfunction with the development of Alzheimer's disease-like pathology in OXYS rats.Fast Green FCF Alleviates Pain Hypersensitivity and Down-Regulates the Levels of Spinal P2X4 Expression and Pro-inflammatory Cytokines in a Rodent Inflammatory Pain Model.The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases
P2860
Q26749031-0ED5DCA9-7D23-4F0D-808C-EAF6EDE4F7E5Q38719556-8A60EC4E-19F8-44BD-AA4C-42E5BF05E88BQ39157893-723A2A03-3483-4330-BECD-0F170EF50C96Q41528659-CD648BB6-37AA-44F3-97DC-FC6DE999925CQ42002912-72069642-1AC2-4F70-8C7A-9BF185117A28Q42367885-69F43A57-BFBF-4923-BD5E-FBACA92B3FB8Q45838619-B257F9BC-CC00-4D99-9313-AC0B79AF12CAQ47571865-5FD55427-C1FE-4F64-B945-24ABBB2284D7Q48184328-3EE6D385-A674-4398-BE9B-71D632B5520AQ49182621-D0C752EE-A4CE-4B91-A51A-EEB2FF925777Q50417222-6690E3DA-0E6E-48EE-B0E4-45FD3FB1A2EFQ55027191-2283484E-BE47-4C25-B154-49AA7FA1261FQ58787876-2412110D-34A8-4BB5-87F3-56E9C17C88AB
P2860
Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
@en
type
label
Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
@en
prefLabel
Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
@en
P2093
P2860
P1433
P1476
Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
@en
P2093
Deepa Ajit
Gary A Weisman
Jean M Camden
Lucas T Woods
P2860
P304
P356
10.1016/J.NEUROPHARM.2015.10.031
P50
P577
2015-10-28T00:00:00Z